Annual Total Liabilities
$61.95 B
+$2.53 B+4.25%
31 December 2023
Summary:
AstraZeneca annual total liabilities is currently $61.95 billion, with the most recent change of +$2.53 billion (+4.25%) on 31 December 2023. During the last 3 years, it has risen by +$10.86 billion (+21.26%). AZN annual total liabilities is now -6.24% below its all-time high of $66.08 billion, reached on 31 December 2021.AZN Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$64.12 B
-$625.00 M-0.97%
30 September 2024
Summary:
AstraZeneca quarterly total liabilities is currently $64.12 billion, with the most recent change of -$625.00 million (-0.97%) on 30 September 2024. Over the past year, it has increased by +$5.25 billion (+8.92%). AZN quarterly total liabilities is now -4.74% below its all-time high of $67.31 billion, reached on 30 September 2021.AZN Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AZN Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.3% | +8.9% |
| 3 y3 years | +21.3% | -4.7% |
| 5 y5 years | +32.9% | +41.7% |
AZN Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -6.2% | +21.3% | -4.7% | +8.9% |
| 5 y | 5 years | -6.2% | +32.9% | -4.7% | +42.5% |
| alltime | all time | -6.2% | +1248.8% | -4.7% | +1295.9% |
AstraZeneca Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $64.12 B(-1.0%) |
| June 2024 | - | $64.74 B(-0.1%) |
| Mar 2024 | - | $64.79 B(+4.6%) |
| Dec 2023 | $61.95 B(+4.3%) | $61.95 B(+5.2%) |
| Sept 2023 | - | $58.87 B(-0.4%) |
| June 2023 | - | $59.13 B(-2.9%) |
| Mar 2023 | - | $60.88 B(+2.4%) |
| Dec 2022 | $59.42 B(-10.1%) | $59.42 B(+0.7%) |
| Sept 2022 | - | $59.03 B(-2.6%) |
| June 2022 | - | $60.63 B(-5.1%) |
| Mar 2022 | - | $63.91 B(-3.3%) |
| Dec 2021 | $66.08 B(+29.3%) | $66.08 B(-1.8%) |
| Sept 2021 | - | $67.31 B(+16.2%) |
| June 2021 | - | $57.95 B(+14.8%) |
| Mar 2021 | - | $50.48 B(-1.2%) |
| Dec 2020 | $51.09 B(+9.2%) | $51.09 B(+1.2%) |
| Sept 2020 | - | $50.49 B(+9.1%) |
| June 2020 | - | $46.27 B(+2.8%) |
| Mar 2020 | - | $44.99 B(-3.8%) |
| Dec 2019 | $46.78 B(+0.4%) | $46.78 B(+3.4%) |
| Sept 2019 | - | $45.24 B(-3.4%) |
| June 2019 | - | $46.82 B(-4.5%) |
| Mar 2019 | - | $49.03 B(+5.2%) |
| Dec 2018 | $46.61 B(-0.2%) | $46.61 B(-2.7%) |
| Sept 2018 | - | $47.91 B(+1.8%) |
| June 2018 | - | $47.07 B(-3.4%) |
| Mar 2018 | - | $48.71 B(+4.3%) |
| Dec 2017 | $46.71 B(+1.9%) | $46.71 B(-4.9%) |
| Sept 2017 | - | $49.14 B(-1.1%) |
| June 2017 | - | $49.71 B(+7.6%) |
| Mar 2017 | - | $46.18 B(+0.7%) |
| Dec 2016 | $45.86 B(+10.4%) | $45.86 B(-5.1%) |
| Sept 2016 | - | $48.31 B(-1.5%) |
| June 2016 | - | $49.03 B(+2.8%) |
| Mar 2016 | - | $47.68 B(+14.8%) |
| Dec 2015 | $41.55 B(+6.7%) | $41.55 B(+13.1%) |
| Sept 2015 | - | $36.75 B(-0.3%) |
| June 2015 | - | $36.87 B(+0.3%) |
| Mar 2015 | - | $36.74 B(-5.7%) |
| Dec 2014 | $38.95 B(+19.3%) | $38.95 B(+9.1%) |
| Sept 2014 | - | $35.70 B(-2.2%) |
| June 2014 | - | $36.49 B(-3.8%) |
| Mar 2014 | - | $37.91 B(+16.1%) |
| Dec 2013 | $32.65 B(+10.3%) | $32.65 B(+6.4%) |
| Sept 2013 | - | $30.67 B(+0.3%) |
| June 2013 | - | $30.57 B(+2.5%) |
| Mar 2013 | - | $29.84 B(+0.9%) |
| Dec 2012 | $29.59 B(+0.8%) | $29.59 B(-2.0%) |
| Sept 2012 | - | $30.19 B(+3.6%) |
| June 2012 | - | $29.15 B(+0.4%) |
| Mar 2012 | - | $29.04 B(-1.1%) |
| Dec 2011 | $29.36 B(-10.2%) | $29.36 B(+3.3%) |
| Sept 2011 | - | $28.42 B(-4.0%) |
| June 2011 | - | $29.59 B(-7.5%) |
| Mar 2011 | - | $31.99 B(-2.2%) |
| Dec 2010 | $32.72 B | $32.72 B(-4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $34.08 B(+5.2%) |
| June 2010 | - | $32.38 B(-2.4%) |
| Mar 2010 | - | $33.19 B(-2.7%) |
| Dec 2009 | $34.10 B(+10.4%) | $34.10 B(+5.4%) |
| Sept 2009 | - | $32.35 B(+0.3%) |
| June 2009 | - | $32.26 B(+4.1%) |
| Mar 2009 | - | $30.99 B(+0.3%) |
| Dec 2008 | $30.89 B(-6.5%) | $30.89 B(-3.4%) |
| Sept 2008 | - | $31.97 B(-6.3%) |
| June 2008 | - | $34.11 B(+1.5%) |
| Mar 2008 | - | $33.59 B(+1.7%) |
| Dec 2007 | $33.04 B(+127.6%) | $33.04 B(+5.9%) |
| Sept 2007 | - | $31.21 B(-4.4%) |
| June 2007 | - | $32.63 B(+110.0%) |
| Mar 2007 | - | $15.54 B(+7.1%) |
| Dec 2006 | $14.52 B(+30.2%) | $14.52 B(+8.8%) |
| Sept 2006 | - | $13.34 B(-0.8%) |
| June 2006 | - | $13.45 B(-7.3%) |
| Mar 2006 | - | $14.52 B(+30.2%) |
| Dec 2005 | $11.15 B(-0.1%) | $11.15 B(-0.1%) |
| Sept 2005 | - | $11.16 B(-1.4%) |
| June 2005 | - | $11.31 B(+1.5%) |
| Mar 2005 | - | $11.15 B(-0.1%) |
| Dec 2004 | $11.15 B(+8.1%) | $11.15 B(+16.8%) |
| Sept 2004 | - | $9.55 B(-17.2%) |
| June 2004 | - | $11.54 B(+1.5%) |
| Mar 2004 | - | $11.37 B(+10.2%) |
| Dec 2003 | $10.32 B(-0.3%) | $10.32 B(+8.7%) |
| Sept 2003 | - | $9.49 B(+0.8%) |
| June 2003 | - | $9.42 B(-9.1%) |
| Mar 2003 | - | $10.36 B(+0.1%) |
| Dec 2002 | $10.35 B(+16.7%) | $10.35 B(+15.2%) |
| Sept 2002 | - | $8.98 B(-2.5%) |
| June 2002 | - | $9.21 B(-3.0%) |
| Mar 2002 | - | $9.50 B(+7.1%) |
| Dec 2001 | $8.87 B(-0.3%) | $8.87 B(-2.7%) |
| Sept 2001 | - | $9.11 B(+2.5%) |
| June 2001 | - | $8.90 B(-6.8%) |
| Mar 2001 | - | $9.54 B(+7.3%) |
| Dec 2000 | $8.90 B(-6.1%) | $8.90 B(-7.4%) |
| Sept 2000 | - | $9.60 B(+3.5%) |
| June 2000 | - | $9.28 B(+4.5%) |
| Mar 2000 | - | $8.88 B(-6.3%) |
| Dec 1999 | $9.47 B(+26.4%) | $9.47 B(+9.8%) |
| Sept 1999 | - | $8.63 B(+2.3%) |
| June 1999 | - | $8.43 B(+12.5%) |
| Dec 1998 | $7.50 B(+60.9%) | $7.50 B(+56.1%) |
| June 1998 | - | $4.80 B(+3.1%) |
| Dec 1997 | $4.66 B(-5.0%) | $4.66 B(-5.0%) |
| Dec 1996 | $4.90 B(+1.4%) | $4.90 B(+1.4%) |
| Dec 1995 | $4.83 B(+5.2%) | $4.83 B(+2.4%) |
| June 1995 | - | $4.72 B(+2.8%) |
| Dec 1994 | $4.59 B(-9.9%) | $4.59 B(-9.9%) |
| Dec 1993 | $5.10 B(-15.3%) | $5.10 B |
| Dec 1992 | $6.02 B(+10.5%) | - |
| Dec 1991 | $5.45 B(+0.5%) | - |
| Dec 1990 | $5.42 B | - |
FAQ
- What is AstraZeneca annual total liabilities?
- What is the all time high annual total liabilities for AstraZeneca?
- What is AstraZeneca annual total liabilities year-on-year change?
- What is AstraZeneca quarterly total liabilities?
- What is the all time high quarterly total liabilities for AstraZeneca?
- What is AstraZeneca quarterly total liabilities year-on-year change?
What is AstraZeneca annual total liabilities?
The current annual total liabilities of AZN is $61.95 B
What is the all time high annual total liabilities for AstraZeneca?
AstraZeneca all-time high annual total liabilities is $66.08 B
What is AstraZeneca annual total liabilities year-on-year change?
Over the past year, AZN annual total liabilities has changed by +$2.53 B (+4.25%)
What is AstraZeneca quarterly total liabilities?
The current quarterly total liabilities of AZN is $64.12 B
What is the all time high quarterly total liabilities for AstraZeneca?
AstraZeneca all-time high quarterly total liabilities is $67.31 B
What is AstraZeneca quarterly total liabilities year-on-year change?
Over the past year, AZN quarterly total liabilities has changed by +$5.25 B (+8.92%)